Aptamer Sciences Inc (KOSDAQ:291650)
944.00
+7.00 (0.75%)
Last updated: Mar 25, 2025
Aptamer Sciences Revenue
In the year 2024, Aptamer Sciences had annual revenue of 1.08B KRW with 345.26% growth. Aptamer Sciences had revenue of 920.07M in the quarter ending December 31, 2024, with 5,471.58% growth.
Revenue
1.08B
Revenue Growth
+281.58%
P/S Ratio
15.57
Revenue / Employee
n/a
Employees
n/a
Market Cap
28.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.08B | 839.63M | 345.26% |
Dec 31, 2023 | 243.19M | -115.07M | -32.12% |
Dec 31, 2022 | 358.25M | 88.98M | 33.04% |
Dec 31, 2021 | 269.28M | 40.77M | 17.84% |
Dec 31, 2020 | 228.51M | -179.09M | -43.94% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 66.19T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 175.23T |
Celltrion | 3,557.30B |
Kia Corporation | 107.45T |
KB Financial Group | 15.01T |